Silphium Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,229
Closed -$277K 41
2022
Q3
$277K Hold
1,229
0.25% 36
2022
Q2
$299K Sell
1,229
-200
-14% -$49K 0.45% 22
2022
Q1
$346K Buy
+1,429
New +$328K 0.41% 44

Other funds holding AMGN

Silphium Asset Management's AMGN Position: Q4 2022 in Review

Silphium Asset Management sold out of Amgen (AMGN) in Q4 2022, closing a stake of 1,229 shares — an estimated $277K sold.

Silphium Asset Management first reported a position in AMGN in Q1 2022 and held it in 3 quarters. The position peaked at $346K in Q1 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Silphium Asset Management reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • Silphium Asset Management sold 1,229 Amgen shares in Q4 2022, an estimated $277K.
  • Silphium Asset Management first reported a position in Amgen in Q1 2022 and held it in 3 quarters.
  • Silphium Asset Management's Amgen position peaked at $346K in Q1 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Silphium Asset Management's 13F filing for Q4 2022, filed 30 Jan 2025.